Warfarin and the vitamin K-dependent gamma-carboxylation system

Trends in Molecular Medicine
R Wallin, S M Hutson

Abstract

Insight into the molecular basis for genetic warfarin resistance has recently been accomplished by the identification of an 18-kDa protein of the endoplasmic reticulum that is targeted by the drug. When expressed in eukaryotic and insect cells, the protein reduces vitamin K1 2,3-epoxide in a warfarin-sensitive reaction. This finding strongly suggests that the protein is part of the vitamin K cycle, which is essential for the production of vitamin K-dependent proteins. Identification of the 18-kDa protein has aided the understanding of the vitamin K-dependent gamma-carboxylation system at the molecular level.

References

Apr 1, 1976·The Journal of Hygiene·M E Wallace, F J MacSwiney
Jan 1, 1991·American Journal of Hematology·C R RouthE G Bovill
Apr 1, 1989·Biochemical Pharmacology·H H Thijssen, L G Baars
May 20, 1988·Cell·B Furie, B C Furie
Jan 1, 1987·The International Journal of Biochemistry·R WallinL F Martin
May 1, 1967·Biochemistry·J T MatschinerJ M Amelotti
Nov 1, 1969·The American Journal of Physiology·M A HermodsonK P Link
Aug 19, 1967·Nature·J H Greavses, P Ayres
May 12, 2000·Hematology/oncology Clinics of North America·C Vermeer, L J Schurgers
Oct 20, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R WallinD C Sane
Mar 6, 2003·Thrombosis Research·Reidar WallinSusan M Hutson
May 21, 2003·European Journal of Clinical Pharmacology·Tadaaki HanataniJunichi Azuma
Feb 7, 2004·Nature·Tao LiDarrel W Stafford

❮ Previous
Next ❯

Citations

Aug 18, 2009·Fish Physiology and Biochemistry·Christel KrossøyRobin Ørnsrud
Apr 25, 2012·The Protein Journal·Anna JonebringAnn Lövgren
Apr 1, 2009·The Journal of Biological Chemistry·Tomoko KomiyamaRobert S Fuller
Aug 12, 2006·Blood·Nadeem WajihReidar Wallin
Nov 21, 2008·Pharmacogenomics·Christos N MarkatosAnthi Travlou
Dec 17, 2008·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Branislava IvanovićDanica Cvetković-Matić
May 13, 2011·Clinical Medicine & Research·James K BurmesterMichael D Caldwell
Oct 17, 2007·Médecine sciences : M/S·Omar BenzakourValérie Coronas
Apr 17, 2013·Journal of Cellular Physiology·V J WoeckelJ P T M Van Leeuwen
Mar 15, 2015·Thrombosis Research·Smith Giri, Lisa K Jennings
Jun 24, 2010·Biochemical and Biophysical Research Communications·Mathieu FerronGerard Karsenty
Feb 20, 2010·Bioorganic & Medicinal Chemistry Letters·Jeremiah J StromichDavid E Lewis
Aug 4, 2011·Journal of Chemical Information and Modeling·Richard D SmithHeather A Carlson
Nov 4, 2009·Artery Research·Michael H KohnHans-Joachim Pelz
Feb 1, 2008·Thrombosis Research·Reidar WallinNadeem Wajih
Feb 1, 2008·Blood Reviews·Giovanna D'AndreaMaurizio Margaglione
Apr 10, 2007·Journal of Autoimmunity·Colin J D RossMichael R Hayden
Mar 5, 2009·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Bent Honoré
Aug 30, 2008·Pharmacotherapy·Nita A Limdi, David L Veenstra
Jun 29, 2007·Journal of Thrombosis and Haemostasis : JTH·R González-ConejeroV Vicente
Jan 24, 2009·Pest Management Science·Ann-Charlotte Heiberg
Mar 5, 2008·Journal of Thrombosis and Haemostasis : JTH·G MarchettiF Bernardi
Aug 31, 2010·Journal of Clinical Pharmacology·Reiner FreyGeorg Wensing
May 2, 2006·European Journal of Medicinal Chemistry·Ilia ManolovNicolay Danchev
Dec 4, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Nita A LimdiT Mark Beasley
Jul 18, 2015·Therapeutic Drug Monitoring·Kaitlyn ShawUNKNOWN CPNDS Clinical Recommendation Group
Aug 2, 2008·The Journal of Toxicological Sciences·Mayumi IshizukaShoichi Fujita
Nov 1, 2012·Bioengineered·Ann Lövgren
Jun 28, 2017·Protein Expression and Purification·Marcela Cristina Corrêa de FreitasDimas Tadeu Covas
Mar 10, 2011·Journal of Cardiovascular Pharmacology·Henk VisscherBruce C Carleton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.